TCI Wealth Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-508
Closed -$16.5K 867
2023
Q1
$16.5K Buy
508
+1
+0.2% +$32 ﹤0.01% 806
2022
Q4
$14.2K Buy
507
+340
+204% +$9.75K ﹤0.01% 856
2022
Q3
$6K Buy
167
+2
+1% +$70 ﹤0.01% 1328
2022
Q2
$5K Hold
165
﹤0.01% 1467
2022
Q1
$5K Sell
165
-62
-27% -$1.62K ﹤0.01% 1526
2021
Q4
$6K Buy
227
+89
+64% +$2.55K ﹤0.01% 1518
2021
Q3
$4K Buy
+138
New +$3.31K ﹤0.01% 1730
2021
Q2
Sell
-96
Closed -$2K 2354
2021
Q1
$2K Buy
+96
New +$1.83K ﹤0.01% 1733
2019
Q4
Sell
-82
Closed -$1K 1576
2019
Q3
$1K Buy
+82
New +$588 ﹤0.01% 1270
2019
Q2
Sell
-62
Closed -$1K 1457
2019
Q1
$1K Hold
62
﹤0.01% 1203
2018
Q4
$1K Sell
62
-18
-23% -$416 ﹤0.01% 1198
2018
Q3
$2K Hold
80
﹤0.01% 1024
2018
Q2
$2K Buy
80
+18
+29% +$341 ﹤0.01% 1066
2018
Q1
$1K Hold
62
﹤0.01% 1126
2017
Q4
$1K Buy
+62
New +$874 ﹤0.01% 1174
2017
Q3
Sell
-32
Closed -$1K 1341
2017
Q2
$1K Hold
32
﹤0.01% 1121
2017
Q1
$1K Buy
+32
New +$614 ﹤0.01% 1075

Other funds holding EVH

TCI Wealth Advisors's EVH Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Evolent Health (EVH) in Q2 2023, closing a stake of 508 shares — an estimated $16.5K sold.

TCI Wealth Advisors first reported a position in EVH in Q1 2017 and held it in 17 quarters. The position peaked at $16.5K in Q1 2023. 217 funds tracked by Wall St. Rank hold EVH as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Evolent Health position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 508 Evolent Health shares in Q2 2023, an estimated $16.5K.
  • TCI Wealth Advisors first reported a position in Evolent Health in Q1 2017 and held it in 17 quarters.
  • TCI Wealth Advisors's Evolent Health position peaked at $16.5K in Q1 2023.
  • 217 funds tracked by Wall St. Rank held Evolent Health as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.